Common Contracts
4 similar Warrant Amendment Agreement contracts by Neurotrope, Inc.
WARRANT AMENDMENT AGREEMENTWarrant Amendment Agreement • September 30th, 2020 • Neurotrope, Inc. • Pharmaceutical preparations • New York
This Warrant Amendment Agreement (this “Agreement”), dated as of September __, 2020, is by and between Neurotrope, Inc., a Nevada corporation (the “Company”), and the undersigned holder (the “Holder”) of Series F warrants to purchase shares of the Company’s common stock, $0.0001 par value (the “Common Stock”).
WARRANT AMENDMENT AGREEMENTWarrant Amendment Agreement • September 30th, 2020 • Neurotrope, Inc. • Pharmaceutical preparations • New York
This Warrant Amendment Agreement (this “Agreement”), dated as of September __, 2020, is by and between Neurotrope, Inc., a Nevada corporation (the “Company”), and the undersigned holder (the “Holder”) of Series H warrants to purchase shares of the Company’s common stock, $0.0001 par value (the “Common Stock”).
WARRANT AMENDMENT AGREEMENTWarrant Amendment Agreement • September 30th, 2020 • Neurotrope, Inc. • Pharmaceutical preparations • New York
This Warrant Amendment Agreement (this “Agreement”), dated as of September __, 2020, is by and between Neurotrope, Inc., a Nevada corporation (the “Company”), and the undersigned holder (the “Holder”) of Series G warrants to purchase shares of the Company’s common stock, $0.0001 par value (the “Common Stock”).
WARRANT AMENDMENT AGREEMENTWarrant Amendment Agreement • September 30th, 2020 • Neurotrope, Inc. • Pharmaceutical preparations • New York
This Warrant Amendment Agreement (this “Agreement”), dated as of September __, 2020, is by and between Neurotrope, Inc., a Nevada corporation (the “Company”), and the undersigned holder (the “Holder”) of Series E warrants to purchase shares of the Company’s common stock, $0.0001 par value (the “Common Stock”).
